RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.9200
+0.0293 (3.29%)
Jun 18, 2026, 4:00 PM EDT - Market closed
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $41.49 million as of June 18, 2026. Its market cap has decreased by -18.38% in one year.
Market Cap
41.49M
Enterprise Value
29.32M
1-Year Change
-18.38%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $41.49M, a decrease of -39.55%. That is a compound annual growth rate of -9.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 41.49M | 34.76% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyperion DeFi | 46.03M |
| Genenta Science | 44.12M |
| Telomir Pharmaceuticals | 44.01M |
| aTyr Pharma | 43.91M |
| Estrella Immunopharma | 43.25M |
| Metagenomi Therapeutics | 42.92M |
| CervoMed | 41.85M |
| Nutriband | 40.24M |